Dear Colleague

  • Further to Contractor Update, SPPG Pharmacy and Medicines Management confirmed that New PGD and National Protocol has been developed for use in the administration of the Spikevax® bivalent COVID 19 vaccine to individuals in accordance with the national COVID-19 vaccination programme and can be located HERE.
  • For pharmacy contracts wishing to participate in this COVID-CPVS, please return by email your completed contract to your local office contact as soon as possible.
  • If you have any queries please contact Deirdre McAree (deirdre.mcaree@hscni.net).
  • Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Colleague

Please find attached correspondence from Helen McNamee of the Community Development and Health Network (CDHN), seeking pharmacist participants for a focus group on the social determinants of medication safety.  A flyer providing further information is available here.

  • The focus group will take place on Thursday 22nd September via Zoom from 10:30 to 11:45. 
  • Participants will receive a £10 e-voucher from CDHN.

For further information contact caoimheshields@cdhn.org or visit the CDHN website here.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

  • CPNI are keen to qualify and understand the effects of network pressures such as workforce, workload and medicine supply and the impact this has on patients, communities and pharmacy teams.
  • To capture this information, we have compiled a short survey to allow contractors to share, at a high level, their experiences of these pressures. We would appreciate if you would complete the survey available HERE before Monday, 19 September 2022. It will take approximately 5 minutes to complete.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Colleague

  • Further to yesterday’s Contractor Update, SPPG Pharmacy and Medicines Management confirmed that New PGD and National Protocol for the administration of inactivated influenza vaccine to individuals in accordance with the national influenza vaccination programme Inactivated Influenza Vaccine.
  • For pharmacy contracts wishing to participate in this Flu-CPVS or COVID-CPVS, please return by email your completed contract to your local office contact as soon as possible.
  • If you have any queries please contact Deirdre McAree (deirdre.mcaree@hscni.net).
  • Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

  • CPNI are keen to qualify and understand the effects of network pressures such as workforce, workload and medicine supply and the impact this has on patients, communities and pharmacy teams.
  • To capture this information, we have compiled a short survey to allow contractors to share, at a high level, their experiences of these pressures. We would appreciate if you would complete the survey available HERE before Monday, 19 September 2022. It will take approximately 5 minutes to complete.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
Please find correspondence HERE from Kathryn Turner, Pharmacy Lead, Strategic Planning and Performance Group.

SUMMARY

  • The programme officially launches from 19 September 2022, it is recognised that not all community pharmacies will be able to start on that date and that start dates will be subject to vaccine deliveries.
  • Community pharmacies paired with care homes will receive vaccination stocks first, and other CPVS pharmacies will start to receive deliveries in the following weeks.
    • Pharmacies vaccinating in care homes will receive notification of initial quotas available for both flu and COVID-19 vaccines shortly. These quotas will be increased as further vaccine stock arrives in Northern Ireland.
    • The remainder of CPVS pharmacies will receive notification of quotas in due course.
  • Community pharmacy contractors should plan to use Spikevax Bivalent (Moderna) (or Comirnaty Bivalent (Pfizer) vaccines if deployed to community pharmacy) for all booster doses and Spikevax wild-type (original Moderna) for primary doses where required.
  • 98% of care homes are now paired with a CPVS pharmacy. Each pharmacy that has notified the SPPG has been allocated vaccine stock which can now be ordered from Movianto.
  • Contractors are advised that there is currently no requirement to submit any weekly waste reports. However, it should be monitored closely and kept to a minimum.
  • A letter and vaccination checklist has been circulated to the managers of RQIA registered nursing and residential care homes in Northern Ireland, which provides information about the Autumn programme and the preparations required. This communication is available HERE.
  • PGDs have been approved and will be available on the CPVS webpage. National Protocols are being finalised and will also be available shortly.
  • Updated resources are available on the PHA webpages below:
  • The VMS software update will run this evening from 8pm to 10pm. The system will be offline during the update and pharmacies will not be able to access the system during this period.
    • Paper vaccination record forms are available HERE.

ACTION

  • Contractors and pharmacists involved in the provision of this service are asked to review the correspondence.
  • For pharmacy contracts wishing to participate in this Flu-CPVS or COVID-CPVS, please return by email your completed contract to your local office contact as soon as possible.
  • If you have any queries please contact Deirdre McAree (deirdre.mcaree@hscni.net).
  • Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive